Daplyza 5 mg Tablet – SGLT2 Inhibitor for Type 2 Diabetes
Daplyza 5 mg Tablet – SGLT2 Inhibitor for Type 2 Diabetes
Daplyza 5 mg Tablet – SGLT2 Inhibitor for Type 2 Diabetes
Description
Daplyza 5 mg Tablet – Efficient Blood Sugar Regulation
Daplyza 5 mg tablet contains dapagliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor. By blocking SGLT2 in the kidneys, it lowers blood sugar in people with type 2 diabetes by increasing glucose excretion through urine.
It’s indicated for glycemic control, plus it offers cardiovascular and renal protection: reducing hospitalization for heart failure and slowing kidney decline in high-risk patients.


